{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:43:32Z","timestamp":1771065812320,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["10758"],"award-info":[{"award-number":["10758"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.breast.2023.103611","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T02:31:46Z","timestamp":1700879506000},"page":"103611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families"],"prefix":"10.1016","volume":"73","author":[{"given":"Maartje A.C.","family":"Schreurs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel A.","family":"Adank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Margriet","family":"Coll\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"Hollestelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjanka K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-0857","authenticated-orcid":false,"given":"Maartje J.","family":"Hooning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.breast.2023.103611_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies","volume":"74","author":"Consortium","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.breast.2023.103611_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2023.103611_bib4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ejca.2013.01.009","article-title":"Excess breast cancer risk in first degree relatives of CHEK2*1100delC positive familial breast cancer cases","volume":"49","author":"Adank","year":"2013","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.breast.2023.103611_bib5","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1158\/0008-5472.CAN-07-5187","article-title":"Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.2005.05.5160","article-title":"Increased risk of breast cancer associated with CHEK2*1100delC","volume":"25","author":"Weischer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.breast.2023.103611_bib7","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","article-title":"Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer","volume":"29","author":"Cybulski","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.103611_bib9","series-title":"Stichting opsporting erfelijke Tumoren","year":"2023"},{"key":"10.1016\/j.breast.2023.103611_bib10","series-title":"Richtlijnendatabase","year":"2022"},{"issue":"8","key":"10.1016\/j.breast.2023.103611_bib12","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.breast.2023.103611_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229999","article-title":"Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: a multi-methods study","volume":"15","author":"Archer","year":"2020","journal-title":"PLoS ONE [Electronic Resource]"},{"issue":"3","key":"10.1016\/j.breast.2023.103611_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","article-title":"CanRisk tool-A web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants","volume":"30","author":"Carver","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.breast.2023.103611_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41436-020-0884-4","article-title":"Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort","volume":"22","author":"Lakeman","year":"2020","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.breast.2023.103611_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-156-9-201205010-00006","article-title":"Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis","volume":"156","author":"Nelson","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.breast.2023.103611_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gim.2016.147","article-title":"Genetic modifiers of CHEK2*1100delC-associated breast cancer risk","volume":"19","author":"Muranen","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.breast.2023.103611_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/CMAR.S144619","article-title":"Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis","volume":"10","author":"Liu","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"17","key":"10.1016\/j.breast.2023.103611_bib19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.2011.1590","article-title":"Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.breast.2023.103611_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/aje\/kwk054","article-title":"Alcohol consumption and breast cancer risk in the Women's Health Study","volume":"165","author":"Zhang","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.breast.2023.103611_bib21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Collaborative Group on Hormonal Factors in Breast C. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.breast.2023.103611_bib22","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive Use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidem Biomar"},{"issue":"9","key":"10.1016\/j.breast.2023.103611_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jmedgenet-2019-106072","article-title":"Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1\/2 breast cancer families","volume":"56","author":"Lakeman","year":"2019","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib24","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1038\/s41467-020-19966-5","article-title":"The role of polygenic risk and susceptibility genes in breast cancer over the course of life","volume":"11","author":"Mars","year":"2020","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.breast.2023.103611_bib25","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1200\/JCO.20.01992","article-title":"Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score","volume":"39","author":"Gao","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.103611_bib26","article-title":"Comprehensive breast cancer risk assessment for CHEK2 and ATM pathogenic variant carriers incorporating a polygenic risk score and the tyrer-cuzick model","volume":"5","author":"Gallagher","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.breast.2023.103611_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg-2022-108502","article-title":"Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases","volume":"60","author":"Lakeman","year":"2023","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.breast.2023.103611_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/1055-9965.EPI-22-0756","article-title":"Incorporating alternative polygenic risk scores into the BOADICEA breast cancer risk prediction model","volume":"32","author":"Mavaddat","year":"2023","journal-title":"Cancer Epidem Biomar"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.breast.2023.103611_bib32","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1200\/JCO.21.00999","article-title":"Management of women with breast cancer and pathogenic variants in genes other than BRCA1 or BRCA2","volume":"39","author":"Robson","year":"2021","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.breast.2023.103611_bib33","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/jmg-2022-108806","article-title":"Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study","volume":"59","author":"Yang","year":"2022","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.breast.2023.103611_bib35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jnci\/djr079","article-title":"Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study","volume":"103","author":"Cuzick","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.breast.2023.103611_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djz149","article-title":"Mammographic density change and risk of breast cancer","volume":"112","author":"Azam","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.breast.2023.103611_bib37","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/bjc.2011.118","article-title":"Polygenic susceptibility to prostate and breast cancer: implications for personalised screening","volume":"104","author":"Pashayan","year":"2011","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2023.103611_bib38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","article-title":"Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model","volume":"4","author":"Pashayan","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","article-title":"Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness","volume":"155","author":"Schousboe","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.breast.2023.103611_bib40","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr3110","article-title":"Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement","volume":"14","author":"Darabi","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.breast.2023.103611_bib41","doi-asserted-by":"crossref","first-page":"W292","DOI":"10.2214\/AJR.10.6049","article-title":"The relationship of mammographic density and age: implications for breast cancer screening","volume":"198","author":"Checka","year":"2012","journal-title":"AJR Am J Roentgenol"}],"updated-by":[{"DOI":"10.1016\/j.breast.2024.103724","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623007373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623007373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:46:59Z","timestamp":1760777219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623007373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":38,"alternative-id":["S0960977623007373"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.103611","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.breast.2024.103724","asserted-by":"object"}]},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.103611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103611"}}